|

Cizutamig Clinical Trials

3 actively recruiting trials

Also known as: CND106

Pipeline

Phase 1: 3

Top Sponsors

  • Candid Therapeutics2
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Indications

  • Rheumatoid Arthritis (RA1
  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1
  • Arthritis1
  • Generalized Myasthenia Gravis1

Other3 trials

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Phase 1
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
Phase 1
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.